Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M and Peto J on behalf of the ARTISTIC Trial Study Group. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening, Health Technol Assess 2009;13(51)
Hanney S, Buxton M, Green C, Coulson D, Raftery J. An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess 2007;11(53) http://www.ncchta.org/project/1440.asp
Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K and Stone D. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess 2007;11(49) http://www.ncchta.org/project/1217.asp
Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C (2006) Evaluation of the ventricular assist device programme in the UK, Health Technol Assess 2006;10(48) http://www.ncchta.org/project/1256.asp
Buxton M, Caine N, Chase D, et al. A review of the evidence on the effects and costs of Implantable Cardioverter Defibrillator (ICD) therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context, Health Technol Assess 2006;10(27) http://www.ncchta.org/project/1208.asp
Peveler R, Kendrick A, Buxton M, et al. Randomised controlled trial to compare the cost effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine, Health Technol Assess 2005;9(16) http://www.ncchta.org/project/1101.asp
Townsend J, Buxton M, Harper G. Prioritisation of health technology assessment. The PATHS model: methods and case studies, Health Technol Assess 2003;7(20) http://www.ncchta.org/project/971.asp
Kennedy ADM, Sculpher MJ, Coulter A, Dwyer N, Rees M, Horsley S, et al. A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia, Health Technol Assess 2003;7(8) http://www.ncchta.org/project/898.asp
Bryan S, Weatherburn G, Bungay H, et al. The cost-effectiveness of magnetic resonance imaging for investigation of the knee joint, Health Technol Assess 2001;5(27) http://www.ncchta.org/project/909.asp
Robert G, Milne R. Positron emission tomography: establishing priorities for health technology assessment, Health Technol Assess, 1999;3(16) http://www.ncchta.org/project/1026.asp
Robert G, Stevens A, Gabbay J. 'Early warning systems' for identifying new health care technologies, Health Technol Assess, 1999;3(13) http://www.ncchta.org/project/961.asp
Zeuner D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis, Health Technol Assess, 1999;3(11) http://www.ncchta.org/project/915.asp
Johnston K, Buxton M, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials, Health Technol Assess 1999;3(6) http://www.ncchta.org/project/935.asp
Fitzpatrick R, Shortall E, Sculpher M, et al. Primary total hip replacement surgery: a structured review of outcomes and modelling of cost-effectiveness associated with different prostheses, Health Technol Assess 1998;2(20) http://www.ncchta.org/project/890.asp
Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials, Health Technol Assess 1998;2(14) http://www.ncchta.org/project/934.asp
Sculpher M, Petticrew M, Kelland J, Elliott RA, Holdright DR, Buxton M. Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions, Health Technol Assess 1998;2(10) http://www.ncchta.org/project/875.asp
Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales, Health Technol Assess 1997;1(3) http://www.ncchta.org/project/902.asp
